Laboratorio Reig Jofre S.A.
Research Laboratorio Reig Jofre S.A. (0RB1) on Bullrun: P/E 40.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0RB1
- ExchangeLSE
- CountrySpain
- CurrencyEUR
- P/E40.7
- Financial periodFY2024
- RevenueEUR 338.90M
- Revenue growth7.2%
- Net incomeEUR 10.47M
- Free cash flowEUR 11.08M
Valuation Snapshot
P/E is 40.7.
About Laboratorio Reig Jofre S.A.
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health;
Frequently asked questions
What is Laboratorio Reig Jofre S.A.'s P/E ratio?
Laboratorio Reig Jofre S.A.'s price-to-earnings (P/E) ratio is 40.7.
What does Laboratorio Reig Jofre S.A. do?
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products.